Lv11
90 积分 2020-05-19 加入
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
1小时前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
2小时前
已完结
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
12天前
已完结
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study
14天前
已完结
Cross-priming in cancer immunology and immunotherapy
5个月前
已完结
Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway
5个月前
已关闭
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
5个月前
已完结
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)
1年前
已完结
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
1年前
已完结
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy
1年前
已完结
皖公网安备34019202002308
